Aurinia Pharmaceuticals
AUPH
AUPH
188 hedge funds and large institutions have $417M invested in Aurinia Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 56 increasing their positions, 54 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 198 → 188 (-10)
18% less capital invested
Capital invested by funds: $506M → $417M (-$88.9M)
26% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 31
Holders
188
Holding in Top 10
1
Calls
$23.8M
Puts
$12.7M
Top Buyers
| 1 | +$49.1M | |
| 2 | +$16.3M | |
| 3 | +$6.27M | |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$4.91M |
| 5 |
Two Sigma Investments
New York
|
+$4.54M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$8.14M | |
| 3 | -$7.55M | |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$5.87M |
| 5 |
Barclays
London,
United Kingdom
|
-$3.33M |